Richard P Tobin

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 9

Top Topics

Peritoneal Dialysis

Top Venues

Cell death & disease

Science immunology

Clinical & translational immunology

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Nabanita Mukherjee, Elizabeth Katsnelson, Tonya M Brunetti, Kylie Michel, Kasey L Couts, Karoline A Lambert, William A Robinson, Martin D McCarter, David A Norris, Richard P Tobin, Yiqun G Shellman
MCL1 inhibition targets Myeloid Derived Suppressors Cells, promotes antitumor immunity and enhances the efficacy of immune checkpoint blockade. Cell death & disease 15 (3) (2024)
Nabanita Mukherjee, Elizabeth Katsnelson, Tonya M Brunetti, Kylie Michel, Kasey L Couts, Karoline A Lambert, William A Robinson, Martin D McCarter, David A Norris, Richard P Tobin, Yiqun G Shellman
MCL1 inhibition targets Myeloid Derived Suppressors Cells, promotes antitumor immunity and enhances the efficacy of immune checkpoint blockade. Cell death & disease 15 (3) (2024)
Nabanita Mukherjee, Elizabeth Katsnelson, Tonya M Brunetti, Kylie Michel, Kasey L Couts, Karoline A Lambert, William A Robinson, Martin D McCarter, David A Norris, Richard P Tobin, Yiqun G Shellman
MCL1 inhibition targets Myeloid Derived Suppressors Cells, promotes antitumor immunity and enhances the efficacy of immune checkpoint blockade. Cell death & disease 15 (3) (2024)
Nabanita Mukherjee, Elizabeth Katsnelson, Tonya M Brunetti, Kylie Michel, Kasey L Couts, Karoline A Lambert, William A Robinson, Martin D McCarter, David A Norris, Richard P Tobin, Yiqun G Shellman
MCL1 inhibition targets Myeloid Derived Suppressors Cells, promotes antitumor immunity and enhances the efficacy of immune checkpoint blockade. Cell death & disease 15 (3) (2024)
William H Palmer, Laura-Ann Leaton, Ana Campos Codo, Bergren W Crute, James Roest, Shiying Zhu, Jan Petersen, Richard P Tobin, Patrick S Hume, Matthew Stone, Adrie van Bokhoven, Mark E Gerich, Martin D McCarter, Yuwen Zhu, William J Janssen, Julian P Vivian, John Trowsdale, Andrew Getahun, Jamie Rossjohn, John C Cambier, Liyen Loh, Paul J Norman
Polymorphic KIR3DL3 expression modulates tissue-resident and innate-like T cells. Science immunology 8 (84) (2023)
William H Palmer, Laura-Ann Leaton, Ana Campos Codo, Bergren W Crute, James Roest, Shiying Zhu, Jan Petersen, Richard P Tobin, Patrick S Hume, Matthew Stone, Adrie van Bokhoven, Mark E Gerich, Martin D McCarter, Yuwen Zhu, William J Janssen, Julian P Vivian, John Trowsdale, Andrew Getahun, Jamie Rossjohn, John C Cambier, Liyen Loh, Paul J Norman
Polymorphic KIR3DL3 expression modulates tissue-resident and innate-like T cells. Science immunology 8 (84) (2023)
William H Palmer, Laura-Ann Leaton, Ana Campos Codo, Bergren W Crute, James Roest, Shiying Zhu, Jan Petersen, Richard P Tobin, Patrick S Hume, Matthew Stone, Adrie van Bokhoven, Mark E Gerich, Martin D McCarter, Yuwen Zhu, William J Janssen, Julian P Vivian, John Trowsdale, Andrew Getahun, Jamie Rossjohn, John C Cambier, Liyen Loh, Paul J Norman
Polymorphic KIR3DL3 expression modulates tissue-resident and innate-like T cells. Science immunology 8 (84) (2023)
Richard P Tobin, Dasha T Cogswell, Victoria M Cates, Dana M Davis, Jessica S W Borgers, Robert J Van Gulick, Elizabeth Katsnelson, Kasey L Couts, Kimberley R Jordan, Dexiang Gao, Eduardo Davila, Theresa M Medina, Karl D Lewis, Rene Gonzalez, Ross W McFarland, William A Robinson, Martin D McCarter
Targeting MDSC differentiation using ATRA: a phase I/II clinical trial combining pembrolizumab and all-trans retinoic acid for metastatic melanoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Victoria M Vorwald, Dana M Davis, Robert J Van Gulick, Robert J Torphy, Jessica S W Borgers, Jared Klarquist, Kasey L Couts, Carol M Amato, Dasha T Cogswell, Mayumi Fujita, Moriah J Castleman, Timothy Davis, Catherine Lozupone, Theresa M Medina, William A Robinson, Laurent Gapin, Martin D McCarter, Richard P Tobin
Circulating CD8 + mucosal-associated invariant T cells correlate with improved treatment responses and overall survival in anti-PD-1-treated melanoma patients. Clinical & translational immunology 11 (1) (2022)